Newly discovered CLEC-2 and its activator, podoplanin (PDPN) – expressed on multiple tumor cells (e.g. colorectal, lung and bladder carcinomas), are key in platelet aggregation and seem to be important in platelet-cancer cell interaction [34][35][36]. The gene discussed is PDPN; the disease is cancer.